This Treatment Guide contains information about lenalidomide maintenance, a treatment used for myeloma patients following high-dose therapy and stem cell transplantation (HDT-SCT).
This publication is part of our Treatment Guide series, a collection of publications covering different drugs used in the treatment of myeloma. Find out more about HDT-SCT in our High-dose therapy and stem cell transplantation Infoguide
Last updated: April 2021
Review date: April 2024
